CN Stock MarketDetailed Quotes

300086 Honz Pharmaceutical

Watchlist
  • 5.16
  • -0.20-3.73%
Market Closed Nov 14 15:00 CST
2.35BMarket Cap-25929P/E (TTM)

Honz Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
18.14%123.63M
-41.29%100.73M
-36.34%114.29M
-46.48%144.4M
-42.03%104.64M
20.35%171.58M
12.61%179.52M
4.35%269.81M
-40.99%180.51M
-25.71%142.57M
Notes receivable and accounts receivable
40.89%64.78M
16.52%70.37M
94.07%109.66M
90.91%139.63M
-51.05%45.98M
-37.21%60.39M
-54.67%56.5M
-52.24%73.14M
27.70%93.94M
-4.92%96.18M
-Notes receivable
253.53%1.13M
-31.21%6.04M
39.85%8.96M
87.04%3.76M
-96.40%318.63K
210.13%8.78M
8.92%6.41M
-46.61%2.01M
46.55%8.84M
2.58%2.83M
-Accounts receivable
39.41%63.66M
24.63%64.33M
101.01%100.69M
91.02%135.87M
-46.34%45.66M
-44.71%51.61M
-57.82%50.09M
-52.39%71.13M
26.01%85.09M
-5.13%93.35M
Other receivables (including interest and dividends)
-4.92%62.65M
0.94%57.84M
-6.27%63.56M
-18.00%55.46M
130.58%65.9M
-28.94%57.31M
-23.35%67.81M
-22.76%67.64M
-66.17%28.58M
71.07%80.64M
-Other receivable
----
0.94%57.84M
----
----
----
-28.94%57.31M
----
-22.76%67.64M
----
71.07%80.64M
Advance payment
17.90%44.09M
-12.65%34.84M
-3.23%37.63M
-68.32%28.1M
57.94%37.39M
79.09%39.88M
24.77%38.89M
315.00%88.7M
-8.77%23.68M
-27.63%22.27M
Inventories
-16.17%221.41M
-1.15%245.22M
8.16%240.87M
38.75%236.43M
50.71%264.13M
38.79%248.07M
15.32%222.69M
-13.88%170.4M
-19.71%175.25M
-18.98%178.74M
Other current assets
-25.12%5.78M
133.24%6.23M
-1.91%3.05M
593.00%5.33M
1,120.49%7.72M
653.91%2.67M
217.72%3.11M
-44.34%768.88K
-84.13%632.78K
-95.09%354.14K
Total current assets
-0.65%522.35M
-11.15%515.22M
0.09%569.05M
-9.11%609.35M
4.61%525.77M
11.36%579.91M
-4.90%568.52M
-6.87%670.46M
-29.43%502.58M
-14.04%520.75M
Non Current assets
Other equity investment
-10.87%5.3M
-10.87%5.3M
-10.87%5.3M
-10.87%5.3M
-3.91%5.95M
-3.91%5.95M
-3.91%5.95M
-3.91%5.95M
11.47%6.19M
11.47%6.19M
Investment real estate
-4.88%226.01M
-4.88%226.01M
-4.88%226.01M
-4.88%226.01M
-8.25%237.61M
-8.25%237.61M
-8.25%237.61M
-6.07%237.61M
3.76%258.98M
3.76%258.98M
Long-term equity investment
----
----
----
----
----
----
----
----
-66.36%4.63M
-66.31%4.68M
Fixed assets
----
-1.81%847.79M
----
----
----
156.97%863.42M
----
169.49%890.94M
----
4.91%335.99M
Fixed assets liquidation
----
--27.9K
----
----
----
----
----
----
----
----
Constru in process
----
63.55%146.29M
----
----
----
-86.95%89.44M
----
-90.96%59.59M
----
13.89%685.27M
Productive biological assets
--21.78K
--17.16K
----
----
----
----
----
----
----
----
Intangible assets
-3.48%155.47M
-3.20%157.84M
-4.36%158.06M
-4.31%160.33M
-17.36%161.08M
-17.45%163.06M
-17.42%165.26M
-17.33%167.55M
3.67%194.91M
22.50%197.52M
Development expenditure
22.86%46.86M
22.86%46.86M
14.50%43.67M
16.85%43.64M
0.80%38.14M
0.80%38.14M
0.80%38.14M
-1.29%37.35M
16.51%37.83M
16.51%37.83M
Goodwill
9.19%20.63M
9.19%20.63M
6.14%20.05M
6.14%20.05M
0.00%18.89M
0.00%18.89M
0.00%18.89M
0.00%18.89M
-15.25%18.89M
-93.88%18.89M
Long deferred expense
-16.97%29.6M
-13.87%32.35M
-1.96%38.03M
-1.26%37.38M
4.78%35.65M
20.28%37.56M
16.88%38.79M
8.10%37.86M
-5.10%34.02M
-22.77%31.23M
Deferred tax assets
35.55%59.35M
17.97%58.04M
-8.96%43.37M
-11.70%42.3M
48.82%43.78M
83.35%49.2M
70.55%47.64M
84.71%47.9M
12.01%29.42M
-7.13%26.83M
Other non current assets
-30.70%26.95M
-52.19%29.61M
-37.08%57.09M
-70.32%33.95M
-69.03%38.88M
-53.27%61.93M
-47.49%90.73M
-30.56%114.37M
-29.12%125.56M
-30.12%132.52M
Total non current assets
0.22%1.57B
0.36%1.57B
-1.16%1.56B
-3.82%1.56B
-9.23%1.56B
-9.84%1.57B
-10.28%1.58B
-6.95%1.62B
2.13%1.72B
-12.09%1.74B
Total assets
-0.00%2.09B
-2.76%2.09B
-0.83%2.13B
-5.37%2.17B
-6.10%2.09B
-4.94%2.15B
-8.91%2.15B
-6.93%2.29B
-7.24%2.22B
-12.54%2.26B
Liabilities
Current liabilities
Short term loan
139.57%201.24M
66.20%174.51M
60.77%169.8M
5.01%139.89M
17.29%84M
-12.15%105M
-27.28%105.62M
-10.29%133.22M
-63.45%71.62M
-53.94%119.52M
Notes payable and accounts payable
-26.31%73.58M
-27.92%75.56M
9.11%63.82M
35.92%78.02M
48.21%99.85M
25.35%104.83M
-39.46%58.49M
-48.90%57.4M
-42.15%67.37M
-39.33%83.63M
-Notes payable
-85.55%5.78M
-85.55%5.78M
----
----
--40M
--40M
----
----
----
----
-Accounts payable
13.29%67.8M
7.64%69.78M
9.11%63.82M
35.92%78.02M
-11.17%59.85M
-22.48%64.83M
-39.46%58.49M
-48.90%57.4M
-42.15%67.37M
-39.33%83.63M
Contract liabilities
-20.23%11.16M
42.52%25.43M
-39.57%14.42M
-88.72%10.79M
33.37%13.99M
31.20%17.85M
61.50%23.87M
266.55%95.66M
-3.43%10.49M
-51.63%13.6M
Advance receipts
1,034.86%240K
797.87%240K
48.01%12.3K
-33.33%7.78K
--21.15K
--26.73K
--8.31K
--11.68K
----
----
Salaries payable
-8.29%8.05M
-4.72%8.17M
-18.50%8.66M
0.16%11.09M
-3.93%8.78M
-1.37%8.58M
25.59%10.62M
12.27%11.07M
12.65%9.14M
-36.27%8.7M
Taxs payable
-4.53%15.95M
-34.08%9.85M
80.74%24.81M
28.85%32.2M
12.40%16.71M
-29.43%14.95M
-17.24%13.73M
-2.45%24.99M
26.82%14.86M
55.19%21.18M
Other payable (including interest and dividends)
18.08%73.57M
23.64%74.72M
0.40%70.18M
-1.30%70.44M
13.12%62.31M
5.07%60.44M
20.59%69.9M
17.92%71.36M
-19.35%55.08M
-33.83%57.52M
-Interest payable
----
----
----
----
----
----
--640.69K
----
----
----
-Other payable
----
23.64%74.72M
----
----
----
5.07%60.44M
----
17.92%71.36M
----
-26.19%57.52M
Non current liabilities due within one year
29.74%90.44M
8.94%75.94M
-56.51%37.62M
-65.65%36.77M
-26.75%69.71M
-29.38%69.71M
-11.14%86.51M
6.22%107.05M
215.26%95.17M
234.81%98.72M
Other current liabilities
-20.09%1.45M
38.12%3.19M
-43.20%1.76M
-63.05%1.38M
32.89%1.81M
30.78%2.31M
61.40%3.1M
207.04%3.74M
-33.96%1.36M
0.04%1.77M
Total current liabilities
33.18%475.69M
16.67%447.63M
5.17%391.09M
-24.56%380.59M
9.87%357.18M
-5.18%383.69M
-15.28%371.85M
4.04%504.51M
-26.73%325.1M
-29.12%404.63M
Current liabilities
Long term loan
-19.36%246.06M
-12.91%267.06M
-0.09%322.05M
-5.21%324.98M
-16.15%305.14M
-1.08%306.64M
-4.46%322.33M
-0.20%342.85M
-1.97%363.9M
-21.62%310M
Deferred tax liabilities
-5.71%33.14M
-4.69%33.33M
-2.15%34.04M
-2.16%33.86M
-15.56%35.15M
-15.63%34.97M
-15.70%34.79M
-15.79%34.6M
1.57%41.63M
-2.19%41.45M
Long term deferred income
3.22%50.44M
3.14%51.13M
-5.56%47.49M
-5.54%48.18M
-5.03%48.87M
35.05%49.57M
42.01%50.29M
43.23%51M
43.72%51.46M
1.74%36.71M
Total non current liabilities
-15.29%329.64M
-10.14%351.52M
-0.94%403.58M
-5.00%407.01M
-14.84%389.16M
0.78%391.18M
-1.61%407.4M
1.96%428.45M
1.09%456.99M
-20.48%388.16M
Total liabilities
7.90%805.33M
3.13%799.15M
1.98%794.66M
-15.58%787.6M
-4.57%746.34M
-2.26%774.87M
-8.64%779.25M
3.07%932.96M
-12.69%782.09M
-25.14%792.79M
Shareholders equity
Paid-in capital
1.14%455.12M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
Capital reserve funds
3.89%859.94M
3.43%847.08M
2.86%842.36M
2.14%836.49M
1.07%827.73M
0.00%818.96M
0.00%818.96M
0.00%818.96M
-0.12%818.96M
-0.12%818.96M
Surplus reserve funds
4.00%54.94M
4.00%54.94M
4.00%54.94M
4.00%54.94M
0.00%52.83M
0.00%52.83M
0.00%52.83M
0.00%52.83M
10.80%52.83M
10.80%52.83M
Retained profit
-118.26%-171.39M
-258.03%-149.52M
-123.08%-95.16M
16.21%-48.66M
-494.57%-78.53M
-200.05%-41.76M
-151.23%-42.66M
-144.84%-58.07M
-75.75%19.9M
-36.79%41.74M
Other composite income
-0.94%51.98M
-0.92%51.98M
-0.92%51.98M
-0.92%51.98M
-0.34%52.47M
-0.34%52.47M
-0.34%52.47M
-0.34%52.47M
0.92%52.65M
0.92%52.65M
Shareholders equity without minority interests
-4.13%1.25B
-5.85%1.25B
-2.06%1.3B
2.17%1.34B
-6.44%1.3B
-5.91%1.33B
-8.65%1.33B
-12.48%1.32B
-3.96%1.39B
-1.37%1.42B
Minority interests
-13.94%31.69M
-14.28%32.35M
-15.06%32.44M
-15.41%33.26M
-21.33%36.83M
-20.92%37.74M
-21.45%38.19M
-20.86%39.33M
-5.02%46.81M
-44.20%47.72M
Total shareholder equity
-4.40%1.28B
-6.09%1.29B
-2.43%1.34B
1.66%1.38B
-6.93%1.34B
-6.40%1.37B
-9.06%1.37B
-12.75%1.36B
-4.00%1.44B
-3.78%1.46B
Total liabilityies and equity
-0.00%2.09B
-2.76%2.09B
-0.83%2.13B
-5.37%2.17B
-6.10%2.09B
-4.94%2.15B
-8.91%2.15B
-6.93%2.29B
-7.24%2.22B
-12.54%2.26B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 18.14%123.63M-41.29%100.73M-36.34%114.29M-46.48%144.4M-42.03%104.64M20.35%171.58M12.61%179.52M4.35%269.81M-40.99%180.51M-25.71%142.57M
Notes receivable and accounts receivable 40.89%64.78M16.52%70.37M94.07%109.66M90.91%139.63M-51.05%45.98M-37.21%60.39M-54.67%56.5M-52.24%73.14M27.70%93.94M-4.92%96.18M
-Notes receivable 253.53%1.13M-31.21%6.04M39.85%8.96M87.04%3.76M-96.40%318.63K210.13%8.78M8.92%6.41M-46.61%2.01M46.55%8.84M2.58%2.83M
-Accounts receivable 39.41%63.66M24.63%64.33M101.01%100.69M91.02%135.87M-46.34%45.66M-44.71%51.61M-57.82%50.09M-52.39%71.13M26.01%85.09M-5.13%93.35M
Other receivables (including interest and dividends) -4.92%62.65M0.94%57.84M-6.27%63.56M-18.00%55.46M130.58%65.9M-28.94%57.31M-23.35%67.81M-22.76%67.64M-66.17%28.58M71.07%80.64M
-Other receivable ----0.94%57.84M-------------28.94%57.31M-----22.76%67.64M----71.07%80.64M
Advance payment 17.90%44.09M-12.65%34.84M-3.23%37.63M-68.32%28.1M57.94%37.39M79.09%39.88M24.77%38.89M315.00%88.7M-8.77%23.68M-27.63%22.27M
Inventories -16.17%221.41M-1.15%245.22M8.16%240.87M38.75%236.43M50.71%264.13M38.79%248.07M15.32%222.69M-13.88%170.4M-19.71%175.25M-18.98%178.74M
Other current assets -25.12%5.78M133.24%6.23M-1.91%3.05M593.00%5.33M1,120.49%7.72M653.91%2.67M217.72%3.11M-44.34%768.88K-84.13%632.78K-95.09%354.14K
Total current assets -0.65%522.35M-11.15%515.22M0.09%569.05M-9.11%609.35M4.61%525.77M11.36%579.91M-4.90%568.52M-6.87%670.46M-29.43%502.58M-14.04%520.75M
Non Current assets
Other equity investment -10.87%5.3M-10.87%5.3M-10.87%5.3M-10.87%5.3M-3.91%5.95M-3.91%5.95M-3.91%5.95M-3.91%5.95M11.47%6.19M11.47%6.19M
Investment real estate -4.88%226.01M-4.88%226.01M-4.88%226.01M-4.88%226.01M-8.25%237.61M-8.25%237.61M-8.25%237.61M-6.07%237.61M3.76%258.98M3.76%258.98M
Long-term equity investment ---------------------------------66.36%4.63M-66.31%4.68M
Fixed assets -----1.81%847.79M------------156.97%863.42M----169.49%890.94M----4.91%335.99M
Fixed assets liquidation ------27.9K--------------------------------
Constru in process ----63.55%146.29M-------------86.95%89.44M-----90.96%59.59M----13.89%685.27M
Productive biological assets --21.78K--17.16K--------------------------------
Intangible assets -3.48%155.47M-3.20%157.84M-4.36%158.06M-4.31%160.33M-17.36%161.08M-17.45%163.06M-17.42%165.26M-17.33%167.55M3.67%194.91M22.50%197.52M
Development expenditure 22.86%46.86M22.86%46.86M14.50%43.67M16.85%43.64M0.80%38.14M0.80%38.14M0.80%38.14M-1.29%37.35M16.51%37.83M16.51%37.83M
Goodwill 9.19%20.63M9.19%20.63M6.14%20.05M6.14%20.05M0.00%18.89M0.00%18.89M0.00%18.89M0.00%18.89M-15.25%18.89M-93.88%18.89M
Long deferred expense -16.97%29.6M-13.87%32.35M-1.96%38.03M-1.26%37.38M4.78%35.65M20.28%37.56M16.88%38.79M8.10%37.86M-5.10%34.02M-22.77%31.23M
Deferred tax assets 35.55%59.35M17.97%58.04M-8.96%43.37M-11.70%42.3M48.82%43.78M83.35%49.2M70.55%47.64M84.71%47.9M12.01%29.42M-7.13%26.83M
Other non current assets -30.70%26.95M-52.19%29.61M-37.08%57.09M-70.32%33.95M-69.03%38.88M-53.27%61.93M-47.49%90.73M-30.56%114.37M-29.12%125.56M-30.12%132.52M
Total non current assets 0.22%1.57B0.36%1.57B-1.16%1.56B-3.82%1.56B-9.23%1.56B-9.84%1.57B-10.28%1.58B-6.95%1.62B2.13%1.72B-12.09%1.74B
Total assets -0.00%2.09B-2.76%2.09B-0.83%2.13B-5.37%2.17B-6.10%2.09B-4.94%2.15B-8.91%2.15B-6.93%2.29B-7.24%2.22B-12.54%2.26B
Liabilities
Current liabilities
Short term loan 139.57%201.24M66.20%174.51M60.77%169.8M5.01%139.89M17.29%84M-12.15%105M-27.28%105.62M-10.29%133.22M-63.45%71.62M-53.94%119.52M
Notes payable and accounts payable -26.31%73.58M-27.92%75.56M9.11%63.82M35.92%78.02M48.21%99.85M25.35%104.83M-39.46%58.49M-48.90%57.4M-42.15%67.37M-39.33%83.63M
-Notes payable -85.55%5.78M-85.55%5.78M----------40M--40M----------------
-Accounts payable 13.29%67.8M7.64%69.78M9.11%63.82M35.92%78.02M-11.17%59.85M-22.48%64.83M-39.46%58.49M-48.90%57.4M-42.15%67.37M-39.33%83.63M
Contract liabilities -20.23%11.16M42.52%25.43M-39.57%14.42M-88.72%10.79M33.37%13.99M31.20%17.85M61.50%23.87M266.55%95.66M-3.43%10.49M-51.63%13.6M
Advance receipts 1,034.86%240K797.87%240K48.01%12.3K-33.33%7.78K--21.15K--26.73K--8.31K--11.68K--------
Salaries payable -8.29%8.05M-4.72%8.17M-18.50%8.66M0.16%11.09M-3.93%8.78M-1.37%8.58M25.59%10.62M12.27%11.07M12.65%9.14M-36.27%8.7M
Taxs payable -4.53%15.95M-34.08%9.85M80.74%24.81M28.85%32.2M12.40%16.71M-29.43%14.95M-17.24%13.73M-2.45%24.99M26.82%14.86M55.19%21.18M
Other payable (including interest and dividends) 18.08%73.57M23.64%74.72M0.40%70.18M-1.30%70.44M13.12%62.31M5.07%60.44M20.59%69.9M17.92%71.36M-19.35%55.08M-33.83%57.52M
-Interest payable --------------------------640.69K------------
-Other payable ----23.64%74.72M------------5.07%60.44M----17.92%71.36M-----26.19%57.52M
Non current liabilities due within one year 29.74%90.44M8.94%75.94M-56.51%37.62M-65.65%36.77M-26.75%69.71M-29.38%69.71M-11.14%86.51M6.22%107.05M215.26%95.17M234.81%98.72M
Other current liabilities -20.09%1.45M38.12%3.19M-43.20%1.76M-63.05%1.38M32.89%1.81M30.78%2.31M61.40%3.1M207.04%3.74M-33.96%1.36M0.04%1.77M
Total current liabilities 33.18%475.69M16.67%447.63M5.17%391.09M-24.56%380.59M9.87%357.18M-5.18%383.69M-15.28%371.85M4.04%504.51M-26.73%325.1M-29.12%404.63M
Current liabilities
Long term loan -19.36%246.06M-12.91%267.06M-0.09%322.05M-5.21%324.98M-16.15%305.14M-1.08%306.64M-4.46%322.33M-0.20%342.85M-1.97%363.9M-21.62%310M
Deferred tax liabilities -5.71%33.14M-4.69%33.33M-2.15%34.04M-2.16%33.86M-15.56%35.15M-15.63%34.97M-15.70%34.79M-15.79%34.6M1.57%41.63M-2.19%41.45M
Long term deferred income 3.22%50.44M3.14%51.13M-5.56%47.49M-5.54%48.18M-5.03%48.87M35.05%49.57M42.01%50.29M43.23%51M43.72%51.46M1.74%36.71M
Total non current liabilities -15.29%329.64M-10.14%351.52M-0.94%403.58M-5.00%407.01M-14.84%389.16M0.78%391.18M-1.61%407.4M1.96%428.45M1.09%456.99M-20.48%388.16M
Total liabilities 7.90%805.33M3.13%799.15M1.98%794.66M-15.58%787.6M-4.57%746.34M-2.26%774.87M-8.64%779.25M3.07%932.96M-12.69%782.09M-25.14%792.79M
Shareholders equity
Paid-in capital 1.14%455.12M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M
Capital reserve funds 3.89%859.94M3.43%847.08M2.86%842.36M2.14%836.49M1.07%827.73M0.00%818.96M0.00%818.96M0.00%818.96M-0.12%818.96M-0.12%818.96M
Surplus reserve funds 4.00%54.94M4.00%54.94M4.00%54.94M4.00%54.94M0.00%52.83M0.00%52.83M0.00%52.83M0.00%52.83M10.80%52.83M10.80%52.83M
Retained profit -118.26%-171.39M-258.03%-149.52M-123.08%-95.16M16.21%-48.66M-494.57%-78.53M-200.05%-41.76M-151.23%-42.66M-144.84%-58.07M-75.75%19.9M-36.79%41.74M
Other composite income -0.94%51.98M-0.92%51.98M-0.92%51.98M-0.92%51.98M-0.34%52.47M-0.34%52.47M-0.34%52.47M-0.34%52.47M0.92%52.65M0.92%52.65M
Shareholders equity without minority interests -4.13%1.25B-5.85%1.25B-2.06%1.3B2.17%1.34B-6.44%1.3B-5.91%1.33B-8.65%1.33B-12.48%1.32B-3.96%1.39B-1.37%1.42B
Minority interests -13.94%31.69M-14.28%32.35M-15.06%32.44M-15.41%33.26M-21.33%36.83M-20.92%37.74M-21.45%38.19M-20.86%39.33M-5.02%46.81M-44.20%47.72M
Total shareholder equity -4.40%1.28B-6.09%1.29B-2.43%1.34B1.66%1.38B-6.93%1.34B-6.40%1.37B-9.06%1.37B-12.75%1.36B-4.00%1.44B-3.78%1.46B
Total liabilityies and equity -0.00%2.09B-2.76%2.09B-0.83%2.13B-5.37%2.17B-6.10%2.09B-4.94%2.15B-8.91%2.15B-6.93%2.29B-7.24%2.22B-12.54%2.26B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data